Pharma

Jaipur, 26th June 2019: Netmeds.com, ‘India ki Pharmacy’ celebrates 4 successful years of providing affordable and quality healthcare solutions to its patrons with exciting offers and deals, exclusively between 26th to 29th June 2019. Customers can avail super saver deals with up to 70% on OTC Products and flat 20% discount on medicines. Our patrons can also avail an additional flat 10% cashback using Amazon Pay....

Hyderabad, 31st May 2022: OMRON Healthcare India, one of the leading players in the digital home blood pressure monitoring segment, today announced support towards the #THEBIGSQUEEZE movement to bolster the ongoing ‘May Measurement Month (MMM)’ global campaign in India. This movement aims to encourage people of all ages to get their blood pressure checked in the world’s largest FREE blood pressure screening campaign. The...

Mumbai, April 26, 2022: Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor),Teneligliptin, with Pioglitazone. This is the only available DPP4 and Glitazone combination brand in India for adults with uncontrolled Type 2 diabetes. Glenmark has launched this FDC under the brand...

New Delhi/Mumbai, May 11, 2022: Amid the ongoing COVID pandemic and the crisis created by it, (JBCPL) JB Chemicals & Pharmaceuticals Ltd., has emerged as the fastest growing pharmaceuticals company amongst the top 25 companies in the Indian Pharmaceutical Market during the Financial Year 2021-22 registering an impressive growth rate of 29% outperforming the market rate of 18% as per...

Export-Import Bank of India (India Exim Bank) concluded a USD 100 mn loan agreement with Japan Bank for International Cooperation (JBIC), along with three Japanese private financial institutions, namely, MUFG Bank, Ltd., the Bank of Kyoto, Ltd., and the Hachijuni Bank, Ltd., on May 23, 2022, on the side-lines of the Quad Leaders' Summit. The purpose of this facility...

New Delhi, April 30, 2022: India’s largest B2B platform for medical supplies – MEDIKABAZAAR, join hands with India Health Link (IHL), a PHYGITAL health and medical device start-up, which has come up with first-of-its-kind human-centric preventive healthcare program that aims to bridge the primary healthcare gaps in India. India Health Link (IHL) has introduced a first-of-its-kind connected ‘user centric’ and award-winning...

Mumbai, Maharashtra, India...The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of icare4u, a comprehensive program to support the mental and physical health of millions of Indians affected by disorders caused by excessive inflammation.The innovative program is being launched at a critical time, with many Indians overwhelmed by the ongoing pandemic and finding it even harder...

National, 21 May 2022: - Regrow Biosciences, an Indian-centric global biotech company, is glad to announce a breakthrough achievement of getting a USFDA nod for conducting a phase II trial of its lead  product 'OSSGROW,' an orphan drug that helps in effectively treating  Osteonecrosis, in the US market. The accomplishment reflects the brand's commitment to delivering a safe, effective,...

Mumbai, 20th May 2022: India Business Excellence Fund – IV, a fund managed and advised by MOPE (MO Alternate Investment Advisors Private Limited ), has agreed to make a primary investment of upto INR 194.4 crore (USD 25 million) in Pathkind Diagnostics Private Limited (“Pathkind”/ “Company”), a pathology focused diagnostics services chain with operations across 23 states in India. Established in 2016, Pathkind is one of the fastest growing diagnostics services chain in India. It is promoted by Mr. Sanjeev Vashishta and the promoters of Mankind Pharma. Pathkind operates...

IIFL Securities, India’s leading distribution and broking firm, has launched a unique product Advisory Anytime Anywhere (AAA) – a tablet which allows youngsters to start their own business at no fixed cost. Those who would like to start a financial advisory business, but are deterred by the entry barriers of manpower, office space, SEBI registration, research inputs and...